Evidence map›Paper›PMID 22800583›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2012

Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles.

Caitlin W Burke, Jung Soo Suk, Anthony J Kim, Yu-Han J Hsiang, Alexander L Klibanov, Justin Hanes, Richard J Price

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. YAP and TAZ regulate cell volume.The Journal of cell biology · 2019
    Article
  15. CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities.International journal of molecular sciences · 2019
    Review
  16. Article
  17. Applications of Ultrasound to Stimulate Therapeutic Revascularization.International journal of molecular sciences · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Caitlin W BurkeBiomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Jung Soo Suk
Anthony J Kim
Yu-Han J Hsiang
Alexander L Klibanov
Justin Hanes
Richard J Price
University of Virginia · USJohns Hopkins University · US

Funding

Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused UltrasoundR01CA164789 · NCI · UNIVERSITY OF VIRGINIA · PI HANES, JUSTIN S., PRICE, RICHARD J. · 2012 to 2016
$3.1M
Arteriogenesis by Ultrasonic Microbubble DestructionR01HL074082 · NHLBI · UNIVERSITY OF VIRGINIA · PI PRICE, RICHARD J. · 2006 to 2010
$1.7M
New Gene Vectors for Cystic Fibrosis (CF): Extra- & Intracellular BarriersR01EB003558 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI HANES, JUSTIN S. · 2007 to 2010
$1.4M
NCI NIH HHS 1R01 CA164789NCI NIH HHS R01 CA164789NHLBI NIH HHS R01 HL074082NHLBI NIH HHS R01 HL74082NIBIB NIH HHS 1R01 EB003558NIBIB NIH HHS R01 EB003558
6 · The paper itself

Abstract

Our goal was to enhance ultrasound (US)-targeted skeletal muscle transfection through the use of poly(ethyleneglycol) (PEG)/polyethylenimine (PEI) nanocomplex gene carriers and adjustments to US and microbubble (MB) parameters. C57BL/6 mice received an intravenous infusion of MBs and either "naked" luciferase plasmid or luciferase plasmid condensed in PEG/PEI nanocomplexes. Pulsed ultrasound (1 MHz; 0.6 MPa or 0.8 MPa) was applied to the right hindlimb for 12 min. Luciferase activity in both hindlimbs was assessed at 3, 5, 7, and 10 days post-treatment by bioluminescent imaging. When targeted to hindlimb using unsorted MBs and 0.6 MPa US, 7 days after treatment, we observed a >60-fold increase in luciferase activity in PEG/PEI nanocomplex-treated muscles over muscles treated with "naked" plasmid DNA. Luciferase activity was consistently greater after treatment with PEG/PEI nanocomplexes at 0.6 MPa as compared to 0.8 MPa. The combination of small diameter MBs and 0.6 MPa US also resulted in significantly greater gene expression when compared to concentration matched intramuscular injections, a control condition in which considerably more PEG/PEI nanocomplexes were present in tissue. This result suggests that, in addition to facilitating PEG/PEI nanocomplex delivery from the bloodstream to tissue, US enhances transfection via one or more secondary mechanisms, including increased cellular uptake and/or trafficking to the nucleus of PEG/PEI nanocomplexes. We conclude that PEG/PEI nanocomplexes may be used to markedly enhance the amplitude of US-MB-targeted skeletal muscle transfection and that activating "small" MBs with a moderate level (0.6 MPa) of acoustic pressure can further enhance these effects.

Indexed as

MicrobubblesUltrasonicsAnimalsDNAGenetic VectorsLuciferasesMiceMice, Inbred C57BLMuscle, SkeletalPlasmidsPolyethylene GlycolsPolyethyleneimineSerum AlbuminTransfectionDNALuciferasespoly(ethylene glycol)-co-poly(ethyleneimine)Polyethylene GlycolsPolyethyleneimineSerum Albumin

Identifiers

PMID22800583
PMCPMC3438364
OpenAlexW1996133494

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.